Six Novel NonsynonymousCYP1A2Gene Polymorphisms: Catalytic Activities of the Naturally Occurring Variant Enzymes-Reference-Cited by-同舟云学术

Six Novel NonsynonymousCYP1A2Gene Polymorphisms: Catalytic Activities of the Naturally Occurring Variant Enzymes

Published:2003-10-16 Issue:1 Volume:308 Page:300-306
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Murayama Norie,Soyama Akiko,Saito Yoshiro,Nakajima Yukiko,Komamura Kazuo,Ueno Kazuyuki,Kamakura Shiro,Kitakaze Masafumi,Kimura Hideo,Goto Yu-ichi,Saitoh Osamu,Katoh Masaaki,Ohnuma Teiichi,Kawai Mitsuru,Sugai Kenji,Ohtsuki Taisuke,Suzuki Chieko,Minami Narihiro,Ozawa Shogo,Sawada Jun-ichi

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference33 articles.

1. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites

2. Detection of Three Genetic Polymorphisms in the 5′-Flanking Region and Intron 1 of Human CYP1A2 in the Japanese Population

3. Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Advanced Technologies—Nanotechnology, Genomics Technology, and 3D Printing Technology—In Precision Anesthesia: A Comprehensive Narrative Review;Pharmaceutics;2023-09-06

2. Development and characterization of pFluor50, a fluorogenic-based kinetic assay system for high-throughput inhibition screening and characterization of time-dependent inhibition and inhibition type for six human CYPs;2023-08-17

3. Pharmacogenomics in psychiatric diseases;Pharmacogenomics;2023

4. The determination of the Paraxanthine/Caffeine ratio as a metabolic biomarker for CYP1A2 activity in various human matrices by UHPLC-ESIMS/MS;Talanta;2021-11

5. Advanced oxidation protein products downregulate CYP1A2 and CYP3A4 expression and activity via the NF-κB-mediated signaling pathway in vitro and in vivo;Laboratory Investigation;2021-05-24